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Penile Calciphylaxis: A Rare Case of Penile Lesion
Dear Editor, We read with great interest the recent article titled "Digital Gangrene in a Dialysis Patient Due to Calciphylaxis and Systemic Polyarteritis Nodosa: A Diagnostic Dilemma" by Jain et al. published in your esteemed journal. [1] With our similar experience on "penile calciphylaxis", a rare site for calcific uremic arteriolopathy (CUA), we aim to increase the awareness amongst our readers about this rare entity.
A 53-year-old male with a medical history significant for end-stage renal disease (ESRD), on regular hemodialysis (HD) for last 2 years, coronary artery disease, diabetes mellitus type 2, and hypertension presented due to penile lesion and pain at local site of 1 month duration [ Figure 1a ].
Computed tomography of the abdomen/pelvis revealed marked calcification of the arterial tree throughout Foot X-ray done for ankle pain also showed calcified vessels [ Figure 2A ]. Blood test suggested hypocalcemia, hypovitaminosis D, hyperphosphatemia, and hyperparathyroidism. Considering clinical features, imaging findings of extensive vascular calcification and lab findings, a diagnosis of penile CUA was made. Currently, he is receiving regular hemodialysis, sodium thiosulphate injection, cinacalcet, and sevelamer.
CUA is a rare and fatal complication of ESRD commonly involving legs, abdomen, and buttocks. Penis and, breast have been rarely reported as a site of CUA in the medical literature. Other common differentials of penile lesions are balanitis, bechet's syndrome, sexually transmitted diseases, malignancy, Peyronie's disease, syringoma calcification and so on. [2] Jain et al. reported a concurrent occurrence of vasculitis and CUA in their patient which underscores the importance of considering combination of possibilities in a single case. [1] Vasculitis workup was negative in our case. Diagnosis of CUA usually involves skin biopsy, however the same is contraindicated in suspected case of penile CUA due to the fear of worsening necrosis. [3] Review on penile CUA done by Ohta et al. (17 patients) and Cohen et al. (11 patients) showed poor outcome. [4, 5] It is important for the readers to know how to differentiate penile CUA from necrotic fasciitis and monckeberg medial calcific sclerosis. [6] Treatment approach involves: (a) Treatment of electrolyte abnormalities with noncalcium phosphate binders like sevelamer and lanthanum (for hyperphosphatemia), cinacalcet (for hyperparathyroidism) with target Ca 2+ × P0 4 2+ of <55 mg 2 /dL 2 (b) Injection of 25 g sodium thiosulphate intravenously thrice every week on the days of HD (c) Control of penile pain with narcotics (d) Surgical approach involves penectomy with or without parathyroidectomy (for refractory hyperparathyroidism).
The overall mortality of penile CUA has been reported as 64% by Karpman et al. [7] None of the treatments have shown better outcomes than the other. [8] Calcium deposition in vital organs can potentially compromise the system functionality. [9] Several novel therapies are being tried (hyperbaric oxygen, tissue plasminogen activator, intracavernosal prostaglandin and so on) with variable success rate.
The important take-home points from our case are: (a) All penile lesions in an ESRD on HD should be evaluated for penile CUA (b) Once common causes are ruled out, penile CUA is considered among differentials, and usually penile biopsy is not recommended (c) Despite best efforts, penile CUA is associated with high mortality rate.
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